Proteome Sciences (GB:PRM) has released an update.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
Proteome Sciences has reported a dip in revenues and gross profit in H1 2024 compared to the previous year but anticipates a resurgence in orders following the launch of their new TMTpro 35plex tags. The company is optimistic about returning to growth with increased orders in Q3 and the development of their innovative plexDIA tags, which are entering licensing discussions. Additionally, their U.S. lab has begun delivering projects, and a CEO transition is underway with Dr. Mariola Soehngen stepping down in January 2025.
For further insights into GB:PRM stock, check out TipRanks’ Stock Analysis page.